Also known as Agenerase
Amprenavir (Agenerase, GlaxoSmithKline) is a protease inhibitor used to treat HIV infection. It was approved by the Food and Drug Administration on April 15, 1999, for twice-a-day dosing instead of needing to be taken every eight hours. The convenient dosing came at a price, as the dose required is 1,200 mg, delivered in eight very large gel capsules.
Source: WikipediaPatients are most commonly prescribed amprenavir to treat blastomycosis, rabies, west nile virus, and pick disease.
Critical Interactions
Significant Interactions
Patients taking amprenavir most commonly experience side effects like diarrhea, nausea, and vomiting.